These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast. Williams AN; Kelso JM Ann Allergy Asthma Immunol; 2007 Nov; 99(5):467-8. PubMed ID: 18051219 [No Abstract] [Full Text] [Related]
33. Chymodiactin postmarketing surveillance. Demographic and adverse experience data in 29,075 patients. Agre K; Wilson RR; Brim M; McDermott DJ Spine (Phila Pa 1976); 1984; 9(5):479-85. PubMed ID: 6387953 [TBL] [Abstract][Full Text] [Related]
34. The use of iohexol in patients with previous reactions to ionic contrast material. A multicenter clinical trial. Siegle RL; Halvorsen RA; Dillon J; Gavant ML; Halpern E Invest Radiol; 1991 May; 26(5):411-6. PubMed ID: 2055737 [TBL] [Abstract][Full Text] [Related]
35. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. Broome CB; Schiff RI; Friedman HS Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic and predictive test procedures in patients with life-threatening anaphylactic and anaphylactoid drug reactions. Assem ES Allergol Immunopathol (Madr); 1984; 12(1):61-70. PubMed ID: 6203389 [TBL] [Abstract][Full Text] [Related]
37. Anaphylactoid reaction to iopamiro (after pretreatment). Roberts M; Fisher M Australas Radiol; 1992 May; 36(2):144-6. PubMed ID: 1520176 [TBL] [Abstract][Full Text] [Related]